These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 903916

  • 41. A new class of nitrosoureas. VI. Synthesis and antitumor activity of 3-substituted-1-(2-chloroethyl)-3-(methyl-alpha-D-glucopyranosid-2-yl)-1-nitrosoureas.
    Morikawa T, Takeda M, Arai Y, Tsujihara K.
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2386-92. PubMed ID: 7139813
    [No Abstract] [Full Text] [Related]

  • 42. Antitumor activities of 3-(methyl-alpha-D-glucopyranos-6-YL)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M, Sekido S, Ninomiya K, Sekine J, Ueno S.
    Gan; 1976 Feb; 67(1):137-9. PubMed ID: 1269854
    [No Abstract] [Full Text] [Related]

  • 43. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
    Inoue K, Fujimoto S, Ogawa M.
    Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
    [Abstract] [Full Text] [Related]

  • 44. Antineoplastic agents. 1. Synthesis and antineoplastic activities of chloroethyl- and methylnitrosourea analogues of thymidine.
    Lin TS, Fischer PH, Shiau GT, Prusoff WH.
    J Med Chem; 1978 Jan; 21(1):130-3. PubMed ID: 563461
    [Abstract] [Full Text] [Related]

  • 45. Nitrosourea derivatives of tertiary phosphine oxides.
    Gugova R, Varbanov S, Raikov Z, Demirov G, Todorov D, Ilarionova.
    Pharmazie; 1991 Aug; 46(8):603. PubMed ID: 1798718
    [No Abstract] [Full Text] [Related]

  • 46. A comparison of a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea with various antitumor agents with respect to therapeutic ratios in L1210 leukemia systems.
    Fujimoto S, Ogawa M.
    J Pharmacobiodyn; 1987 Jul; 10(7):341-5. PubMed ID: 3694427
    [Abstract] [Full Text] [Related]

  • 47. [Antitumor activity of several new pentopyranosyl-chloroethylnitrosoureas].
    Grouiller A, Navarro ML, Nonga B, Molière P, Santini R, Voulot C, Pacheco H.
    C R Seances Soc Biol Fil; 1987 Jul; 181(2):128-36. PubMed ID: 2957032
    [Abstract] [Full Text] [Related]

  • 48. Nitrosoureidonucleosides.
    Montgomery JA, Thomas HJ.
    J Med Chem; 1979 Sep; 22(9):1109-13. PubMed ID: 490557
    [Abstract] [Full Text] [Related]

  • 49. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
    Gosse C, Atassi G, Letourneux Y, Ardouin P, Gouyette A, Fournier JP, Roger P.
    Anticancer Res; 1988 Sep; 8(6):1419-22. PubMed ID: 3218975
    [Abstract] [Full Text] [Related]

  • 50. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
    Hayat M, Bourut C, Chenu E, Montero JL, Imbach JL, MacDonald JS, Mathé G.
    Cancer Chemother Pharmacol; 1979 Sep; 3(4):217-21. PubMed ID: 161207
    [No Abstract] [Full Text] [Related]

  • 51. 1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
    Farquhar D, Benvenuto J.
    J Med Chem; 1984 Dec; 27(12):1723-7. PubMed ID: 6502603
    [Abstract] [Full Text] [Related]

  • 52. In the search for new anticancer drugs. XXIII: Exploration of a predictive design for anticancer drugs of carbohydrates containing N-nitrosochloroethylamino, N-nitrosomethyl, and N-nitrosoaminoxyl components.
    Sosnovsky G, Rao NU.
    J Pharm Sci; 1991 Jul; 80(7):693-9. PubMed ID: 1658297
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
    Montgomery JA, McCaleb GS, Johnston TP, Mayo JG, Laster WR.
    J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Chemistry and structure-activity studies of the nitrosoureas.
    Montgomery JA.
    Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR.
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract] [Full Text] [Related]

  • 59. The effect of phenobarbital on the toxicity and tumoricidal activity of CCNU in a murine brain tumor model.
    Muller PJ, Tator CH, Bloom M.
    J Neurosurg; 1980 Mar; 52(3):359-66. PubMed ID: 7359190
    [No Abstract] [Full Text] [Related]

  • 60. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S, Ogawa M, Sakurai Y.
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.